Benoît Van Den Eynde

Title: Benoît Van Den Eynde: Innovator in Peptide Research

Introduction

Benoît Van Den Eynde is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of peptide research, particularly in the context of immunology. His work focuses on the development of peptides that have the potential to enhance immune responses.

Latest Patents

Benoît Van Den Eynde holds 1 patent for his invention titled "Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof." This invention relates to peptides that bind to HLA-B35 molecules, facilitating recognition and lysis of the resulting complexes by cytolytic T cells. Additionally, the invention includes nucleic acid molecules that encode these peptides, with some derived from tyrosinase, along with portions of the tyrosinase molecule and its encoding nucleic acid.

Career Highlights

Throughout his career, Benoît has focused on advancing the understanding of peptide interactions and their applications in immunotherapy. His innovative approach has positioned him as a key figure in the field, contributing to the development of therapeutic strategies that leverage the immune system.

Collaborations

Benoît has collaborated with esteemed colleagues such as Annie Ooms and Gérard De Giiovanni. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in peptide technology.

Conclusion

Benoît Van Den Eynde's work exemplifies the intersection of science and innovation in the realm of immunology. His contributions to peptide research are paving the way for future advancements in therapeutic applications.